Literature DB >> 33642636

DELAFLOXACIN, A NOVEL FLUOROQUINOLONE ANTIBIOTIC WITH ACTIVITY AGAINST HOSPITAL-, COMMUNITY- AND LIVESTOCK- ASSOCIATED METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA).

Mollie Maguire1, John E Moore1,2, B Cherie Millar1,2.   

Abstract

Entities:  

Year:  2021        PMID： 33642636      PMCID： PMC7907908     

Source DB:  PubMed          Journal:  Ulster Med J        ISSN： 0041-6193


× No keyword cloud information.
  2 in total

Review 1.  Clinical review of delafloxacin: a novel anionic fluoroquinolone.

Authors:  Bryan T Mogle; Jeffrey M Steele; Stephen J Thomas; KarenBeth H Bohan; Wesley D Kufel
Journal:  J Antimicrob Chemother       Date:  2018-06-01       Impact factor: 5.790

2.  In Vitro Activity of Delafloxacin and Microbiological Response against Fluoroquinolone-Susceptible and Nonsusceptible Staphylococcus aureus Isolates from Two Phase 3 Studies of Acute Bacterial Skin and Skin Structure Infections.

Authors:  S McCurdy; L Lawrence; M Quintas; L Woosley; R Flamm; C Tseng; S Cammarata
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.